RNAi

The molecular machinery involved in RNAi was subsequently revealed (Fig. 3).

Advanced Information: The 2006 Nobel Prize in Physiology or Medicine 2006

Using pharmacological inhibition of DNA-PK activity and DNA-PK deficient adipocytes (obtained from long term RNAi directed against DNA-PKcs mRNAs), a functional link between this two events was established.

PLoS ONE Alerts: New Articles 2008

Using pharmacological inhibition of DNA-PK activity and DNA-PK deficient adipocytes (obtained from long term RNAi directed against DNA-PKcs mRNAs), a functional link between this two events was established.

PLoS ONE Alerts: New Articles Aline Meulle et al. 2008

We now know that dsRNA is both a trigger and intermediate in RNAi.

Craig C. Mello - Autobiography 2007

Merck said Monday it is buying Sirna Therapeutics, a tiny biotech specializing in a hot new drug technology called RNAi, for $1.1 billion in cash, a premium of more than 100%.

Merck's $1 Billion Bet Matthew Herper 2006

Merck said Monday it is buying Sirna Therapeutics, a tiny biotech specializing in a new drug technology called RNAi, for $1.1 billion in cash, a premium of more than 100% to today's closing price.

Merck Makes $1 Billion Bet On Nobel-Winning Discovery Update -- Merck's $1 Billion Bet Matthew Herper 2006

What's more, later research would reveal that genes that create this kind of RNA--known as RNAi, for RNA interference--existed in plants, fruit flies and even people.

Biotech Breakthrough Wins Nobel Prize 2006

By harnessing the natural biological process of RNAi occurring in our cells, the creation of a major new class of medicines, known as RNAi therapeutics, is on the horizon.

Alnylam Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for ALN-TTR01, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis - Yahoo! Finance 2011

By harnessing the natural biological process of RNAi occurring in our cells, the creation of a major new class of medicines, known as RNAi therapeutics, is on the horizon.

Alnylam Launches “Alnylam 5x15” Product Strategy and Provides Guidance and Goals for 2011 - Yahoo! Finance 2011

By harnessing the natural biological process of RNAi occurring in our cells, the creation of a major new class of medicines, known as RNAi therapeutics, is on the horizon.

unknown title 2011